DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,403,750 | +6.3% | 5,658 | +2.8% | 0.16% | +11.1% |
| Q2 2023 | $1,320,720 | +0.7% | 5,503 | +5.7% | 0.14% | -4.6% |
| Q1 2023 | $1,311,616 | -7.9% | 5,204 | -3.0% | 0.15% | -10.1% |
| Q4 2022 | $1,424,509 | +0.2% | 5,367 | -2.5% | 0.17% | -9.2% |
| Q3 2022 | $1,421,000 | +1.1% | 5,503 | -0.7% | 0.18% | +8.8% |
| Q2 2022 | $1,406,000 | -15.3% | 5,543 | -2.0% | 0.17% | +2.4% |
| Q1 2022 | $1,659,000 | -12.9% | 5,656 | -2.3% | 0.17% | -8.8% |
| Q4 2021 | $1,905,000 | +7.9% | 5,789 | -0.2% | 0.18% | -0.5% |
| Q3 2021 | $1,766,000 | +14.2% | 5,800 | +0.6% | 0.18% | +15.8% |
| Q2 2021 | $1,546,000 | +5.5% | 5,764 | -11.5% | 0.16% | 0.0% |
| Q1 2021 | $1,466,000 | +0.8% | 6,514 | -0.5% | 0.16% | -4.8% |
| Q4 2020 | $1,455,000 | +0.5% | 6,548 | -2.6% | 0.17% | -9.3% |
| Q3 2020 | $1,448,000 | +35.3% | 6,725 | +11.2% | 0.18% | +28.0% |
| Q2 2020 | $1,070,000 | +25.7% | 6,050 | -1.6% | 0.14% | +10.0% |
| Q1 2020 | $851,000 | -10.5% | 6,151 | -0.7% | 0.13% | +13.0% |
| Q4 2019 | $951,000 | +5.4% | 6,196 | -0.8% | 0.12% | -3.4% |
| Q3 2019 | $902,000 | -0.4% | 6,246 | -1.5% | 0.12% | -1.7% |
| Q2 2019 | $906,000 | +4.9% | 6,341 | -3.1% | 0.12% | +6.1% |
| Q1 2019 | $864,000 | +8.7% | 6,542 | -15.2% | 0.11% | +8.6% |
| Q4 2018 | $795,000 | +11.7% | 7,711 | +17.7% | 0.10% | +29.6% |
| Q3 2018 | $712,000 | +9.7% | 6,551 | -0.4% | 0.08% | +3.8% |
| Q2 2018 | $649,000 | +2.2% | 6,576 | +1.5% | 0.08% | +1.3% |
| Q1 2018 | $635,000 | +5.3% | 6,481 | -0.3% | 0.08% | +5.5% |
| Q4 2017 | $603,000 | +4.9% | 6,501 | -3.0% | 0.07% | -3.9% |
| Q3 2017 | $575,000 | +10.4% | 6,700 | +8.5% | 0.08% | +1.3% |
| Q2 2017 | $521,000 | +22.3% | 6,173 | +24.0% | 0.08% | +17.2% |
| Q1 2017 | $426,000 | +24.9% | 4,978 | +13.7% | 0.06% | +4.9% |
| Q4 2016 | $341,000 | -0.6% | 4,378 | 0.0% | 0.06% | 0.0% |
| Q3 2016 | $343,000 | -21.0% | 4,378 | +2.0% | 0.06% | -21.8% |
| Q2 2016 | $434,000 | -0.5% | 4,293 | -6.7% | 0.08% | +1.3% |
| Q1 2016 | $436,000 | +10.4% | 4,600 | +8.2% | 0.08% | +8.5% |
| Q4 2015 | $395,000 | +9.1% | 4,250 | 0.0% | 0.07% | +1.4% |
| Q3 2015 | $362,000 | -0.5% | 4,250 | 0.0% | 0.07% | +9.4% |
| Q2 2015 | $364,000 | +0.8% | 4,250 | 0.0% | 0.06% | -1.5% |
| Q1 2015 | $361,000 | -2.7% | 4,250 | -1.7% | 0.06% | -4.4% |
| Q4 2014 | $371,000 | +12.8% | 4,325 | 0.0% | 0.07% | +11.5% |
| Q3 2014 | $329,000 | -4.6% | 4,325 | -1.3% | 0.06% | +5.2% |
| Q2 2014 | $345,000 | +6.5% | 4,381 | +1.5% | 0.06% | +5.5% |
| Q1 2014 | $324,000 | -2.7% | 4,317 | 0.0% | 0.06% | 0.0% |
| Q4 2013 | $333,000 | +16.8% | 4,317 | +5.0% | 0.06% | +10.0% |
| Q3 2013 | $285,000 | +9.6% | 4,112 | 0.0% | 0.05% | +4.2% |
| Q2 2013 | $260,000 | – | 4,112 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |